Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

Cronkhite-Canada syndrome can cause multiple gastrointestinal polyps and various physical symptoms.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Improved care and timely diagnosis are needed for women with PCOD and PCOS, and CystaCare can help.

Cepharanthine may help hair growth by boosting cell growth and VEGF expression.

ILC1-like cells can cause alopecia areata by themselves.

Cepharanthine shows promise as a COVID-19 treatment.

The internship highlighted the pharmacist's important role in health education and community engagement.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

PCOS should be reclassified into two types based on hormone levels and symptoms.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.

A new method accurately measures a drug in skin for cancer therapy research.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Doctors should not have to re-certify.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

The Chi-PCOSQ is effective for assessing health-related quality of life in Chinese women with PCOS.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.